Global analysis of H3K27me3 as an epigenetic marker in prostate cancer progression - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue BMC Cancer Année : 2017

Global analysis of H3K27me3 as an epigenetic marker in prostate cancer progression

Résumé

H3K27me3 histone marks shape the inhibition of gene transcription. In prostate cancer, the deregulation of H3K27me3 marks might play a role in prostate tumor progression.

Dates et versions

hal-01675179 , version 1 (04-01-2018)

Identifiants

Citer

Marjolaine Ngollo, André Lebert, Marine Daures, Gaelle Judes, Khaldoun Rifai, et al.. Global analysis of H3K27me3 as an epigenetic marker in prostate cancer progression. BMC Cancer, 2017, 17 (1), pp.261. ⟨10.1186/s12885-017-3256-y⟩. ⟨hal-01675179⟩
116 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More